Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.

MLA

Piran, Sanaz, et al. “Where Genome Meets Phenome: Rationale for Integrating Genetic and Protein Biomarkers in the Diagnosis and Management of Dilated Cardiomyopathy and Heart Failure.” Journal of the American College of Cardiology, vol. 60, no. 4, July 2012, pp. 283–89. EBSCOhost, https://doi.org/10.1016/j.jacc.2012.05.005.

APA

Piran, S., Liu, P., Morales, A., & Hershberger, R. E. (2012). Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure. Journal of the American College of Cardiology, 60(4), 283–289. https://doi.org/10.1016/j.jacc.2012.05.005

Chicago

Piran, Sanaz, Peter Liu, Ana Morales, and Ray E Hershberger. 2012. “Where Genome Meets Phenome: Rationale for Integrating Genetic and Protein Biomarkers in the Diagnosis and Management of Dilated Cardiomyopathy and Heart Failure.” Journal of the American College of Cardiology 60 (4): 283–89. doi:10.1016/j.jacc.2012.05.005.